RCT NO. 1 – EST vs. EPCS     RCT NO. 2 – EPCS vs. TIPS    
Findings EST (n = 106) EPCS (n = 105) P value EPCS (n = 76) TIPS (n = 78) P value
Cirrhosis on liver biopsy, n (%) 106 (100) 105 (100) 1 76 (100) 78 (100) 1
Esophageal varices on endoscopy, n (%) 106 (100) 105 (100) 1 76 (100) 78 (100) 1
   Size 2+ to 4+ (on scale of 0-4+), n (%) 102 (96) 105 (100) 0.68 71 (92) 69 (88) 0.4
   Active bleeding, n (%) 41 (39) 29 (28) 0.11 37 (49) 50 (52) 0.5
   Clot on varices, n (%) 53 (50) 51 (49) 0.89 45 (63) 40 (52) 0.18
   Red color signs on varices, n (%)   67 (63) 66 (63) 1 34 (47) 35 (45) 1
Gastric varices on endoscopy, n (%) 19 (18) 17 (16) 0.86 25 (33) 28 (36) 0.74
Portal hypertensive gastropathy, n (%) 23 (22) 22 (21) 1 46 (61) 38 (49) 0.15
Laboratory blood tests, median/mean (range)            
   Lowest hemoglobin, g/dL 8.0/8.4 (2.0-8.1) 8.0/8.0 (2.6-11.9) 0.4 7.5/7.4 (2.3-13.7) 7.9/7.9 (2.8-22.5) 0.17
   Lowest hematocrit, % 23.4/22.8 (6.0-39.4) 23.5/23.7 (11.0-35.4) 0.46 22.3/21.85 (2-36.8) 23/22.6 (7.5-32.8) 0.32
   Lowest platelet count, 1,000/mm3 87/97.6 (25-340) 76/95.4 (15-268) 0.36 78.0/88.1 (3-328) 77.5/92.7 (25-296) 0.56
   Serum bilirubin, mg/dL            
      Direct 0.5/1.1 (0.1-12.0) 0.4/0.7 (0.1-3.7) 0.12 0.75/0.91 (0.1-3.7) 0.65/1.29 (0.1-14.7) 0.89
      Total 2.4/3.5 (0.6-15.2) 1.9/27 (0.4-148) 0.25 2.25/2.66 (0.9-7.5) 2.15/3.18 (0.5-25.4) 0.89
   Albumin, g/dL 2.6/2.6 (1.4-3.9) 2.5/2.6 (1.4-4.5) 0.49 2.5/2.78 (1.2-24) 2.4/2.45 (1.6-3.5) 0.43
   Aspartate transaminase, IU/L 73/116 (16-1,359) 66/88 (16-582) 0.37 65/83 (24-351) 67/178 (16-4,010) 0.41
   Alanine transaminase, IU/L 35/54 (11-432) 36/47 (9-582) 0.56 32/43 (13-230) 34/72 (9-645) 0.52
   Alkaline phosphatase, IU/L 86/95 (1.3-367) 79/88 (29-218) 0.2 75/90 (12-476) 75/88 (32-299) 0.9
   International normalized ratio 1.3/2.8 (0.6-5.8) 1.3/1.4 (1.1-2.6) 0.39 1.4/1.5 (1.1-4.1) 1.4/1.5 (1.1-3.0) 0.94
   Arterial ammonia, µmol/L 76/93 (33-253) 75/92 (26-497) 0.83 85/122 (32-2,002) 88/97 (24-251) 0.65
   Creatinine, mg/dL 0.8/1.4 (0.4-10) 0.8/1.0 (0.5-2.7) 0.89 0.8/0.92 (0.4-2.9) 0.8/0.91 (0.4-2.2) 0.94
   Blood urea nitrogen, mg/dL 22/27 (7-85) 21/23 (6-69) 0.22 20/23.1 (5-91) 19/21.1 (4-68) 0.43
   Glucose, mg/dL 133/152 (74-548) 135/157 (60-368) 0.44 128/146 (11-389) 143/154 (89-367) 0.17
   Blood alcohol 0.01% or higher, n (%) 9 (8) 13 (12) 0.29 7 (9) 6 (8) 0.78
   Blood alpha fetoprotein, ng/mL, mean (range) 4 (0-18) 4 (0-10) 0.84 4 (0-118) 4 (0-181) 0.98
   Positive HBV or HCV serology, n (%) 37 (35) 44 (42) 0.32 47 (62) 49 (63) 1
EST-Endoscopic Sclerotherapy; EPCS- Emergency Portacaval Shunt; HBV- Hepatitis B Virus; HCV- Hepatitis C Virus; TIPS-Transjugular Intrahepatic Portosystemic Shunt
Table 2: Findings on liver biopsy, endoscopy, and laboratory blood tests at time of study entry in patients with cirrhosis and bleeding esophageal varices randomized in RCT No. 1 to endoscopic sclerotherapy or emergency portacaval shunt and in RCT No. 2 to TIPS or emergency portacaval shunt.